Samantha N. Seidor
Obstetrics and Gynecology
101 Old Short Hills Road
West Orange, NJ 07052
West Orange, NJ 07052
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
An intravaginal ring that releases three antiviral agents and a contraceptive blocks SHIV-RT infection, reduces HSV-2 shedding, and suppresses hormonal cycling in rhesus macaques.
Journal: Drug delivery and translational research
Published: June 11, 2017
Multipurpose Prevention Approaches with Antiretroviral-Based Formulations.
Journal: Antimicrobial agents and chemotherapy
Published: October 12, 2015
A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 09, 2015
A MIV-150/zinc acetate gel inhibits SHIV-RT infection in macaque vaginal explants.
Journal: PloS one
Published: April 21, 2014
MIV-150-containing intravaginal rings protect macaque vaginal explants against SHIV-RT infection.
Journal: Antimicrobial agents and chemotherapy
Published: March 12, 2014
A combination microbicide gel protects macaques against vaginal simian human immunodeficiency virus-reverse transcriptase infection, but only partially reduces herpes simplex virus-2 infection after a single high-dose cochallenge.
Journal: AIDS research and human retroviruses
Published: October 15, 2013
A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV.
Journal: PloS one
Published: September 30, 2013
Exposure to MIV-150 from a high-dose intravaginal ring results in limited emergence of drug resistance mutations in SHIV-RT infected rhesus macaques.
Journal: PloS one
Published: September 26, 2013
A modified zinc acetate gel, a potential nonantiretroviral microbicide, is safe and effective against simian-human immunodeficiency virus and herpes simplex virus 2 infection in vivo.
Journal: Antimicrobial agents and chemotherapy
Published: June 12, 2013
An intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaques.
Journal: Science translational medicine
Published: September 08, 2012
The nonnucleoside reverse transcription inhibitor MIV-160 delivered from an intravaginal ring, but not from a carrageenan gel, protects against simian/human immunodeficiency virus-RT Infection.
Journal: AIDS research and human retroviruses
Published: July 24, 2012
A single dose of a MIV-150/Zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24 h after gel use.
Journal: AIDS research and human retroviruses
Published: June 29, 2012
Last Updated: 09/26/2026